PAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8:30 AM EST
Conference call and live webcast was previously scheduled for 4:30 PM EST
Lucid Diagnostics strategic advisor and medical diagnostics pioneer Stanley Lapidus to join call
NEW YORK, Feb. 18, 2021 (GLOBE NEWSWIRE)
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced that the Company has moved the time of its business update conference call on Monday, February 22, 2021 to 8:30 AM EST to accommodate the schedule of PAVmed subsidiary Lucid Diagnostics Inc’s (“Lucid”) Strategic Advisor, medical diagnostics pioneer Stanley Lapidus.
Mr. Lapidus will join PAVmed Chairman and Chief Executive Officer Lishan Aklog, M.D., and President and Chief Financial Officer Dennis McGrath on the call. Mr. McGrath will provide a financial update on the Company. Dr. Aklog will provide a business u